doc, yeah but the news says... Under the terms o
Post# of 36537
Quote:
Under the terms of the deal, Generex will receive an
upfront payment of $2.5 million to initiate the Ii-Key vaccine development work to identify swine
flu epitopes for a new Ii-Key vaccine.
That says to "initiate" and "upfront". Something is not clear.